New Finding may Pave way for Better Cocaine Addiction Treatment

High levels of hypocretin molecule in the brain may contribute to cocaine addiction, say researchers at The Scripps Research Institute (TSRI).

Blocking hypocretin molecule in the brain may reduce compulsive drug-seeking behavior in rat models of cocaine addiction, say researchers at The Scripps Research Institute (TSRI), funded by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA). The research, published recently online ahead of print in the journal Biological Psychiatry, shows that blocking hypocretin .

Marisa Roberto, professor in TSRI's Committee on the Neurobiology of Addictive Disorders (CNAD) and co-author of the study with Brooke Schmeichel, a former TSRI researcher now at NIDA, George Koob, the CNAD chairman currently on a leave of absence to direct the NIAAA, and Melissa Herman, a senior research associate at TSRI. "Understanding the mechanisms underlying cocaine addiction is important for identifying potential new targets for therapeutic use."

Drug Abuse | Drug Addiction | Substance Abuse - Overview
The use of Drugs for reasons other than its prescribed recommendation, is known as Drug abuse or substance abuse. Drug abuse or substance abuse is initiated by various biological and social factors.

‘High levels of hypocretin molecule in the brain may contribute to cocaine addiction.’

Cocaine addiction affects millions of people worldwide. In rat models of cocaine addiction researchers blocked "The results of this study would suggest that the hypocretin system could be considered a pharmacological target, with the hopes that such a medication could be used in combination with cognitive behavioral therapies," added Schmeichel.

What Fuels Addiction?

Addiction seems like a simple concept--taking a drug motivates a person to continue to take that drug.

Drug Abuse Screening Test
Drug Abuse Screening Test (DAST) is a screening test to find out if you need professional help with ‘Drug Abuse’ problem. This is only an anonymous self test.

But the molecular mechanisms in the brain that drive addiction are more complex. To design treatments for addiction and relapse, scientists need to understand what motivates a person to transition from occasional drug use to compulsive drug use.

In the new study, the researchers, led by Schmeichel, focused on changes in the central amygdala, a brain region associated with stress and negative emotions during drug withdrawal.

Drug To Treat Diabetes May Help Fight Cocaine Addiction
The drug, Byetta, is derived from a hormone that regulates feeding behavior known as glucagon-like peptide-1, or GLP-1.

Their goal was to better understand the role of a neurotransmitter called hypocretin in the central amygdala. Hypocretin is a main player in the brain's hypothalamic hypocretin/orexin (HCRT) system, a network that sends signals between brain regions and has been shown to influence the brain's reactions to cocaine, nicotine, alcohol and opioids and the desire to relapse. Until now, however, scientists did not fully understand the HCRT's role in cocaine addiction.

For the study, one group of rats was given the option to self-administer cocaine for one hour a day, mimicking conditions of short-term, occasional drug use. A second group had the option to self-administer cocaine for six hours a day, which mimicked the conditions that lead to compulsive drug use and addiction.

Cocaine Addiction - Researchers Discover 'Back Door' Into the Brain
Individuals addicted to cocaine may have difficulty in controlling their addiction because of a previously-unknown 'back door' into the brain.

The researchers found that compulsive cocaine use triggers a dangerous cycle in the brain, with cocaine sensitizing the HCRT system, which motivates further drug-seeking.

Specifically, compulsive cocaine use leads to increased hypocretin, which contributes to overactivity in the central amygdala. This overactivity corresponds with an anxiety-like state in rat models that appears to help maintain the motivation to continue to seek the drug.

"The rats escalate their daily intake as many human users would," said Roberto.

Interestingly, giving the rats an "antagonist" to block HCRT activity at one of the two HCRT receptors in the central amygdala helped reduce their drug-seeking behavior, suggesting a potential role for these compounds in treatments for addiction and relapse.

Source-Eurekalert